Swisse Wellness – Australia’s #1 multivitamin brand – is hitting US mass retail with 15 of its top-selling products available in Walgreens, and aims of $0.5 billion in sales by 2015.
The €55m Tate & Lyle Ventures (TLV) fund has sold off the Fugeia wheat extract business it bought into in 2008 to Cargill’s starches and sweeteners division for an undisclosed sum.
Carmit Candy Industries’ expertize in specialty free-from candy formulations will give a competitive edge to its new line of functional confectionery targeting specific health functions and demographics, it CEO says.
The International Osteoporosis Foundation (IOF) and Fonterra are backing bone health research with a $44,000 Asia-focused grant open to residents of China, Indonesia, Malaysia, the Philippines and Vietnam.
A UK man won a Red Bull ‘VIP trip’ to the 2012 Belgian Grand Prix, only to travel there by budget airline, stay in a spa hotel without a spa, share a bed with his brother and leave the race early.
Unilever and Nestlé say Oxfam missed an opportunity for a wider and more comprehensive debate about food ethics after the NGO published a damning report on the supply chains of the world’s biggest food firms this week.
New funding and licencing deals will help the UK Institute of Food Research (IRF) to take a significant step closer to the commercial use of its model gut systems by international food and drug companies.
Nestlé has bought its second brain health-focused medical foods start-up in eight months after snaffling Red River Pharma-owned Pamlab which makes high-dose vitamin supplements targeting depression, diabetes and Alzheimer’s.
It is hard for a food industry trade show to pack the same level of glamour as, say, the Tokyo Motor Show, so it’s probably best for organisers not to try. But every now and again, in a moment of wild abandon, a celebrity or sports star graces a show’s...
A daily dose of 500mg of L-carnitine coupled with motivation training can help weight loss in overweight individuals, according to a Lonza-sponsored pilot study.
Pharmaceutical omega-3 products are important but will grow more slowly than some expect because of the long timeframe for drug approval, says the chief of the Global Organisation for EPA and DHA Omega-3s (GOED).
Save the Children in the UK has called on infant formula manufacturers like Danone and Nestlé to do more to promote breast feeding – including larger on-pack warnings – after a report it commissioned found the companies were breaking international infant...
DSM’s bulging lipid business has bumped fish-sourced omega-3 oil prices 15% as crude fish oil stock prices skyrocket in the face of increasing demands on global fisheries.
UK food supplements lobby group, Consumers for Health Choice (CHC), has launched a new campaign to keep maximum permitted levels (MPL) for food supplements in UK hands.
Limagrain Céréales Ingrédients (LCI) has extended its fibre range with a new ultra-fine wheat bran ingredient that it says can improve structure, texture and nutrition in a broad range of food and beverages.
Just got off the phone to Ola Snove, the new(ish) CEO of Aker part-owned Norwegian omega-3 specialist Epax. Wanted to know his view on high-end omega-3 prospects that have attracted BASF and DSM to the sector. His word: “Stellar”.
Omega-3 is the undisputed champion of the supplement and health food world. Yet its translation into everyday food products is slow and challenging because of the complex interactions that need to be tracked in a finished food, say experts.
Fish oil, an ingredient with a 150-year plus history as a nutraceutical, continues to be the mainstay of the world’s supply of omega-3s. But, with all of the questions hovering over the health of the oceans, how much longer can suppliers and manufacturers...
Most experts say we have barely scratched the surface when it comes to exploring the commercial potential of microalgae. But who is best-placed to translate this promise into hard cash in the food and dietary supplement market?
German confectionery coatings firm Capol plans to venture into the supplements sector to establish a second business pillar for growth and gain technological knowledge, its CEO says.
A new technology that utilises intestinal stem cells to grown mini gut structures in the lab promises to help probiotic researchers achieve efficient and cost effective research, according to TNO.
Walmark says it will take legal action against a Romanian government agency after one of its officials publicly criticised the eastern European supplement giant’s marketing and market share-gaining methods.
Royal DSM saw 2012 EBIT (operating) profits fall 27% to €635m from €866m in 2011 – but the human and animal nutrition business it has invested €2.4bn in since 2010 added 6% in profit.
Rexam says it will build on its already strong relationship with Red Bull by building a new £115m ($175m) specialty can plant with a 2.2bn capacity for the energy drinks giant in Switzerland.
The final stumbling blocks for the wide use of curcumin have been removed, claims Sabinsa as it launches its ‘next generation’ of curcuminoids offering ‘greater potency, stability and much better bioavailability’.
Four Traditional Chinese Medicines (TCM) sold online have been found to contain lead and mercury and can cause anaemia and brain damage, according to the UK medicines regulator.
Global probiotics leader Chr Hansen is throwing €20m at the expansion of its Danish freeze-drying capacity with increasing global pharma and food supplement demand the key driver.
Charging the private sector for European Food Safety Authority (EFSA) work will not generate enough cash and compromise the agency’s independence, a European Commission working group has found.
Southern Israel-based algae-sourced astanxanthin specialists Algatechnologies has won investment from a UK venture capitalist in a move that will broaden its capacity, R&D and distribution scope for the eye and skin health carotenoid.
A Romanian government official has lodged an official complaint against eastern and central European food supplements mega-brand, Walmark, which it says exploits legal loopholes to bully competitors from market.
Leatherhead Food Research nutrition research manager Roberta Re calls for more rigorous science after pouring over the latest serving of article 13.5 opinions from the European Food Safety Authority (EFSA) in this guest article. All were ultimately refused,...
Food industry trade body FoodDrinkEurope has said a decision to cut research and innovation spending by 11% under the EU’s seven year budget proposal is likely to harm the competitiveness of the European food industry.
EFSA’s health claims panel has rejected 6 article 13.5 health claims for two digestion-focused probiotic submissions; cranberry and UTI; a potato extract and weight management; krill and menstrual discomfort; and fizzy water and GI response.
There is no surprise in the latest batch of European Food Safety Authority (EFSA) article 13.5 health claim rejections as the science presented in six dossiers was “lousy”, a consultant told us today.
Certain combinations of natural products can be as effective as man-made drugs in acting against specific diseases. But the chances of finding an effective combination could be as low as below 3%, according to new research data.
Nutrition Capital Network noted a record 247 deals in the health and wellness sector in 2012. Within that number, the group noted a decline in the number of M&A deals from the previous year, but an increase in financings.
A high intake of calcium from both food and supplements is associated with an increased risk of all-cause mortality and death from heart disease in women, reports a new study.
Contract manufacturer Laboratoire PYC has sliced carbohydrate content by 80% in its latest dietetic whole grain bread product to target the ‘strict diet stage’ in weight management, it said.
US supplier Balchem has joined with Dutch firm Van Eeghen Functional Ingredients (VEFI) to develop the European choline foods and food supplements market, after the nutrient won three EU health claims in 2012.
The International Society of Sports Nutrition (ISSN) has issued a position paper for the use of beta-hydroxy-beta-methylbutyrate (HMB) as a nutritional supplement.
